Is RAPT undervalued or overvalued?
As of 2025-03-26, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is -4.56 USD. This RAPT valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.31 USD, the upside of Rapt Therapeutics Inc is -448.20%. This means that RAPT is overvalued by 448.20%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.56 - -4.56 | -4.56 | -448.20% |
| P/E | (11.68) - (13.87) | (11.27) | -960.0% |
| DDM - Stable | (4.98) - (13.03) | (9.01) | -787.6% |
| DDM - Multi | (0.33) - (0.70) | (0.45) | -134.7% |
| Market Cap (mil) | 172.93 |
| Beta | 2.02 |
| Outstanding shares (mil) | 132.01 |
| Enterprise Value (mil) | 3.20 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.56% |
| Cost of Debt | 5.00% |
| WACC | 8.61% |